UBS Group’s Panbela Therapeutics, Inc. Common Stock PBLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-41
| Closed | -$1.89K | – | 9067 |
|
|
2023
Q2 | $1.89K | Sell |
41
-14
| -25% | -$646 | ﹤0.01% | 6757 |
|
|
2023
Q1 | $14.5K | Buy |
55
+46
| +511% | +$12.1K | ﹤0.01% | 6252 |
|
|
2022
Q4 | $14.9K | Buy |
9
+1
| +13% | +$1.66K | ﹤0.01% | 6840 |
|
|
2022
Q3 | $51K | Buy |
+8
| New | +$51K | ﹤0.01% | 5277 |
|
|
2022
Q2 | – | Hold |
0
| – | -$3K | – | 10392 |
|
|
2022
Q1 | – | Hold |
0
| – | -$5K | – | 8532 |
|
|
2021
Q4 | – | Hold |
0
| – | -$2K | – | 8354 |
|
|
2021
Q3 | – | Hold |
0
| – | -$1K | – | 7942 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 8186 |
|